You are here:--Mining Chemical Libraries for New Antibacterials

Mining Chemical Libraries for New Antibacterials


Speaker: Carl Balibar, Principal Scientist, Merck Research Laboratories

Moderator: Benjamin Blasco, Discovery Senior Project Manager, GARDP


Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds, which mainly come from mining various chemical libraries. In this webinar, Carl Balibar (Merck Research Laboratories) discussed screen design, target bias, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic.


This live webinar including interactive Q&A session was broadcast on 21 May 2019.

If you have questions or comments, please let us know. Do so by posting them in our forum or submitting them via the ‘Talk to an expert’ feature. You can also send questions to: revive@gardp.org

2019-07-11T07:48:26+00:00